MENU
BBIO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BridgeBio Pharma (BBIO) Earnings Date & Reports

A.I. Advisor
published Earnings

BBIO is expected to report earnings to rise 7.16% to -92 cents per share on February 20

BridgeBio Pharma BBIO Stock Earnings Reports
Q4'24
Est.
$-0.92
Q3'24
Beat
by $0.13
Q2'24
Beat
by $0.41
Q1'24
Beat
by $0.72
Q4'23
Missed
by $0.09
The last earnings report on November 12 showed earnings per share of -86 cents, beating the estimate of -99 cents. With 1.93M shares outstanding, the current market capitalization sits at 4.53B.
View a ticker or compare two or three
BBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company which engages in developing transformative medicines to treat patients who suffer from mendelian diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3160 Porter Drive
Phone
+1 650 391-9740
Employees
556
Web
https://www.bridgebio.com